FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
ByteDance is expanding offshore AI compute capacity by partnering with a Southeast Asian cloud provider to access NVI...
Hess Midstream signals a major shift from expansion to cash returns, projecting $850-$900 million in adjusted free ca...
Five major loan-channel partnerships in five days are redefining how borrowers learn about and secure loans. The rapi...
Platform-scale brokerages are redefining how buyer leads are allocated and how loans are funded. The shift, powered b...
Rising fuel costs in May 2026 are shifting the auto market. As Detroit paused on new EV bets, Chinese manufacturers m...
A potential policy showdown between a president and the Fed chair could ripple through markets. This piece explains t...
As AI tools empower both attackers and defenders, the arms race cybersecurity started to redefine personal finance. T...
A GOP lawmaker is proposing language to widen a congressional stock ban bill to cover prediction markets like Kalshi ...
May CPI data show inflation just roared back above 4% driven by energy costs, while some grocery prices ease. Investo...
A New York-based AI startup led by a 21-year-old cofounder pitches clients with a provocative call to skepticism. The...
When life disrupts your routine, smart money decisions matter more than ever. This guide turns a high-profile leaders...